GO:0042823 pyridoxal 5'-phosphate biosynthetic process: Vitamin B6 Activation Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0042823 describes the biosynthesis of pyridoxal 5'-phosphate (PLP), the active form of vitamin B6 and an essential cofactor for numerous enzymes.
• PLP is a versatile electrophilic catalyst involved in transamination, decarboxylation, racemization, and other reactions.
• PLP-dependent enzymes participate in diverse processes including amino acid metabolism, neurotransmitter synthesis, and antibiotic production [5,8].
• Phosphorylation of PLP-dependent enzymes is an emerging regulatory mechanism.
• PLP has been implicated in hypertension and cardiovascular regulation [2,4].
• Research on PLP biosynthesis employs genetic, biochemical, and structural approaches, with CRISPR-based models enabling functional studies [1,3].
Description
Pyridoxal 5'-phosphate (PLP) is the biologically active form of vitamin B6 and serves as an indispensable cofactor for a wide array of enzymatic reactions. The biosynthetic process that generates PLP, designated by the Gene Ontology term GO:0042823 (pyridoxal 5'-phosphate biosynthetic process), encompasses the chemical reactions and pathways leading to the formation of this crucial molecule. Understanding this process is fundamental to comprehending how organisms synthesize and utilize vitamin B6 to sustain essential metabolic functions. PLP-dependent enzymes are involved in numerous cellular processes, including amino acid metabolism, neurotransmitter biosynthesis, and the production of secondary metabolites [5,8]. The importance of PLP extends to human health, as perturbations in PLP homeostasis have been linked to conditions such as hypertension and neurological disorders [2,4]. Moreover, recent studies have revealed unexpected roles for PLP-binding proteins, such as RNA binding, expanding the functional repertoire of this cofactor. Given its central role in metabolism, the PLP biosynthetic process is a subject of intense research interest, with implications for drug development and therapeutic interventions [3,6].
pyridoxal 5'-phosphate biosynthetic process At A Glance
| GO ID | GO:0042823 |
|---|---|
| GO term | pyridoxal 5'-phosphate biosynthetic process |
| Ontology | biological_process |
| Synonym | active vitamin B6 biosynthesis; pyridoxal phosphate anabolism; pyridoxal phosphate biosynthesis; pyridoxal phosphate formation; pyridoxal phosphate synthesis |
| Major function | Synthesis of pyridoxal 5'-phosphate, the active form of vitamin B6 and an essential enzyme cofactor |
| Related enzymes | PLP-dependent enzymes such as transaminases, decarboxylases, and racemases |
| Regulation | Phosphorylation of PLP-dependent enzymes may regulate their activity |
| Disease relevance | Hypertension, neurological disorders, and metabolic diseases [2,4] |
| Research methods | CRISPR knockout, point mutation, knock-in, overexpression, and biochemical assays [1,3] |
What Is GO:0042823?
GO:0042823, pyridoxal 5'-phosphate biosynthetic process, is defined as the chemical reactions and pathways resulting in the formation of pyridoxal phosphate (PLP), which is pyridoxal phosphorylated at the hydroxymethyl group of C-5. PLP is the active form of vitamin B6 and functions as a coenzyme in many enzymatic reactions.
Why Is pyridoxal 5'-phosphate biosynthetic process Important in Cell Biology?
The pyridoxal 5'-phosphate biosynthetic process is critically important because PLP is an essential cofactor for numerous enzymes that participate in fundamental metabolic pathways, including amino acid metabolism, neurotransmitter synthesis, and one-carbon metabolism. Disruptions in PLP biosynthesis or homeostasis can lead to severe physiological consequences, as evidenced by the association of PLP with hypertension and cardiovascular regulation [2,4]. Furthermore, PLP-dependent enzymes are targets for antibiotic and drug development, and understanding their biosynthesis can inform therapeutic strategies [5,8]. The process also intersects with RNA biology, as some PLP-binding proteins have been found to interact with RNA, suggesting broader regulatory roles. Thus, research on PLP biosynthesis is vital for both basic science and translational medicine.
• PLP is a cofactor for over 140 enzymatic activities, including transamination, decarboxylation, and racemization.
• PLP biosynthesis is essential for amino acid metabolism and neurotransmitter production.
• PLP-dependent enzymes are involved in the biosynthesis of antibiotics and other secondary metabolites [5,8].
• Phosphorylation of PLP-dependent enzymes represents a regulatory mechanism that can affect their function.
• PLP has been implicated in blood pressure regulation and hypertension [2,4].
• PLP-binding proteins may have RNA-binding roles, linking PLP to RNA metabolism.
• Defects in PLP biosynthesis can lead to vitamin B6-responsive disorders and neurological symptoms.
• PLP is a target for the development of antimicrobial agents.
• CRISPR-based gene editing enables functional dissection of PLP biosynthetic genes [1,3].
• Understanding PLP biosynthesis can aid in metabolic engineering and drug discovery [3,8].
What Happens During pyridoxal 5'-phosphate biosynthetic process?
Overview of PLP Biosynthesis
In simple terms: PLP is made through a series of chemical steps that convert simple precursors into the active vitamin B6 cofactor.
The biosynthesis of pyridoxal 5'-phosphate (PLP) involves multiple enzymatic steps that transform precursors such as pyridoxine, pyridoxamine, or pyridoxal into PLP. In many organisms, PLP is synthesized de novo from small molecules like glyceraldehyde-3-phosphate and ribose-5-phosphate, or through salvage pathways from vitamin B6 vitamers. The process is tightly regulated to maintain cellular PLP levels, as both deficiency and excess can be detrimental.
Enzymatic Steps and Catalysis
In simple terms: Specific enzymes catalyze each step, often using PLP itself as a cofactor in the process.
The biosynthetic pathway typically involves enzymes such as pyridoxal 5'-phosphate synthase (PdxS) and pyridoxamine 5'-phosphate oxidase (PdxH), which catalyze the formation and oxidation of intermediates. These enzymes utilize sophisticated catalytic mechanisms, including the formation of Schiff base intermediates, to achieve the phosphorylation and oxidation required for PLP production. Some PLP-dependent enzymes are themselves regulated by phosphorylation, adding another layer of control.
Subcellular Localization and Compartmentalization
In simple terms: PLP biosynthesis occurs in specific cellular compartments, depending on the organism.
In bacteria, PLP biosynthesis enzymes are typically cytosolic, while in eukaryotes, the pathway can be distributed across the cytosol and mitochondria. The subcellular localization ensures efficient substrate channeling and regulation. Recent studies have shown that PLP-binding proteins can also localize to the nucleus and interact with RNA, suggesting additional roles beyond metabolism.
Regulation of PLP Homeostasis
In simple terms: Cells control PLP levels by adjusting enzyme activity and expression in response to demand.
PLP homeostasis is maintained through feedback inhibition, transcriptional regulation, and post-translational modifications. For example, phosphorylation of PLP-dependent enzymes can alter their activity and stability. Additionally, the availability of precursors and the activity of salvage enzymes contribute to PLP pool size. Dysregulation of PLP biosynthesis has been linked to hypertension and other disorders [2,4].
Key Genes Involved in GO:0042823 pyridoxal 5'-phosphate biosynthetic process
The following genes and proteins are key players in the pyridoxal 5'-phosphate biosynthetic process and its regulation.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PdxS | Pyridoxal 5'-phosphate synthase, catalyzes formation of PLP from ribose-5-phosphate and glyceraldehyde-3-phosphate | Target for antibacterial drug design |
| PdxT | Glutaminase subunit of PLP synthase, provides ammonia for PLP synthesis | Essential for de novo PLP biosynthesis in bacteria |
| PdxH | Pyridoxamine 5'-phosphate oxidase, oxidizes pyridoxamine 5'-phosphate to PLP | Salvage pathway enzyme, linked to vitamin B6 metabolism |
| PdxK | Pyridoxal kinase, phosphorylates pyridoxal to PLP | Key enzyme in salvage pathway |
| PdxY | Pyridoxal kinase, alternative enzyme for PLP synthesis | Potential target for metabolic engineering |
| PLPBP | PLP-binding protein, may regulate PLP homeostasis | RNA-binding protein with roles in gene regulation |
| GAD1 | Glutamate decarboxylase, PLP-dependent enzyme synthesizing GABA | Neurotransmitter synthesis, epilepsy research |
| GAD2 | Glutamate decarboxylase 2, PLP-dependent | GABA synthesis, neurological disorders |
| AAT | Aspartate aminotransferase, PLP-dependent | Amino acid metabolism, liver function |
| ALT | Alanine aminotransferase, PLP-dependent | Biomarker for liver damage |
| ODC1 | Ornithine decarboxylase, PLP-dependent | Polyamine synthesis, cancer research |
| SHMT | Serine hydroxymethyltransferase, PLP-dependent | One-carbon metabolism, cancer |
| CBS | Cystathionine beta-synthase, PLP-dependent | Homocysteine metabolism, cardiovascular disease |
| GOT1 | Glutamic-oxaloacetic transaminase 1, PLP-dependent | Amino acid metabolism |
| GOT2 | Glutamic-oxaloacetic transaminase 2, PLP-dependent | Mitochondrial metabolism |
| P2RX3 | P2X3 receptor, modulated by PLP | Hypertension and carotid body function |
| Pdx1 | Transcription factor regulating PLP biosynthesis genes | Gene regulation in response to vitamin B6 |
| Pdx2 | Glutaminase involved in PLP synthesis | Bacterial PLP biosynthesis |
How Is pyridoxal 5'-phosphate biosynthetic process Regulated?
The pyridoxal 5'-phosphate biosynthetic process is regulated at multiple levels. Transcriptional control of biosynthetic genes responds to vitamin B6 availability, while feedback inhibition by PLP modulates enzyme activity. Post-translational modifications, particularly phosphorylation, have emerged as a regulatory mechanism for PLP-dependent enzymes, affecting their catalytic activity and interactions. Additionally, PLP-binding proteins such as PLPBP may sequester PLP or modulate its availability, and their RNA-binding activity suggests a broader regulatory role. In hypertension, PLP levels and P2X3 receptor antagonism influence carotid body function, indicating physiological regulation.
pyridoxal 5'-phosphate biosynthetic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| P2RX3 | Hypertension | Knockout mouse, point mutation |
| GAD1 | Epilepsy, GABA deficiency | Knock-in mouse, overexpression |
| SHMT | Cancer, one-carbon metabolism | Knockout cell lines, conditional KO |
| PdxS | Bacterial infection | Bacterial knockout, inhibitor studies |
| PLPBP | Vitamin B6 homeostasis, RNA binding | Knockout, tagged knock-in |
Hypertension and Cardiovascular Disease
PLP has been proposed as a cost-effective treatment candidate for hypertensive patients, and it antagonizes carotid body P2X3 receptors, which are involved in blood pressure regulation [2,4]. Dysregulation of PLP biosynthesis or availability may contribute to hypertension pathogenesis.
Neurological Disorders
PLP is essential for the synthesis of neurotransmitters such as GABA, serotonin, and dopamine. Deficiencies in PLP-dependent enzymes like GAD1 and GAD2 are associated with epilepsy and other neurological conditions. PLP supplementation can ameliorate certain vitamin B6-responsive epilepsies.
Cancer and Metabolic Reprogramming
PLP-dependent enzymes such as SHMT and ODC1 play roles in one-carbon metabolism and polyamine synthesis, which are often dysregulated in cancer. Targeting PLP biosynthesis or utilization may offer therapeutic opportunities.
Infectious Diseases
PLP biosynthesis is essential for many pathogens, making it an attractive target for antimicrobial development. Inhibitors of PLP biosynthetic enzymes have shown promise against bacteria and parasites [5,8].
From pyridoxal 5'-phosphate biosynthetic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate PLP biosynthesis? | CRISPR knockout cell lines |
| What is the effect of a point mutation in a PLP enzyme? | Point mutation knock-in |
| How does PLP binding affect protein localization? | Tagged knock-in (e.g., GFP) |
| Can overexpression of Pdx genes increase PLP levels? | Overexpression cell lines |
| What is the role of PLP in hypertension? | Knockout mouse models |
| How do PLP-dependent enzymes contribute to antibiotic synthesis? | Bacterial knockout and complementation |
How to Study the pyridoxal 5'-phosphate biosynthetic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout | Gene function loss | Identify essential PLP biosynthetic genes |
| Point mutation knock-in | Effect of specific mutations | Study catalytic residues |
| Overexpression | Gain-of-function | Increase PLP production |
| HPLC | PLP concentration | Quantify vitamin B6 levels |
| Mass spectrometry | Protein modifications, metabolites | Detect phosphorylation of PLP enzymes |
| RNA-seq | Transcriptome changes | Identify regulated genes |
| Ribo-seq | Translational efficiency | Study regulation of PLP enzyme synthesis |
| Crystallography | 3D protein structure | Elucidate catalytic mechanism |
Genetic Approaches
CRISPR-Cas9 knockout, point mutation, and knock-in strategies enable precise manipulation of PLP biosynthetic genes. These models help determine gene function and causality in cellular and animal systems [1,3].
Biochemical Assays
Enzymatic activity assays, HPLC quantification of PLP, and mass spectrometry are used to measure PLP levels and enzyme kinetics. These methods are essential for characterizing biosynthetic pathways.
Structural Biology
X-ray crystallography and cryo-EM provide insights into the catalytic mechanisms of PLP biosynthetic enzymes and their regulation by phosphorylation [6,7].
Omics and Systems Biology
Transcriptomics, proteomics, and metabolomics can reveal global changes in PLP metabolism and identify novel regulatory networks. RNA-seq and Ribo-seq are particularly useful for studying translational control.
How CRISPR Can Be Used to Study GO:0042823 pyridoxal 5'-phosphate biosynthetic process
Knockout
CRISPR knockout of PLP biosynthetic genes (e.g., PdxS, PdxH) can abolish PLP production, leading to auxotrophy for vitamin B6. Such models are valuable for studying the essentiality of the pathway and for drug target validation.
Point Mutation
Introducing point mutations in catalytic residues of PLP enzymes via CRISPR can dissect their mechanistic roles. For example, mutating the lysine involved in Schiff base formation can inactivate the enzyme.
Knock-in
Knock-in of tagged versions of PLP enzymes (e.g., GFP or FLAG) allows visualization and immunoprecipitation, facilitating studies of localization, interactions, and dynamics.
Overexpression
CRISPR activation (CRISPRa) or cDNA overexpression can increase PLP enzyme levels, enabling production of PLP for industrial or therapeutic purposes, and studying dose-dependent effects.
How EDITGENE Supports pyridoxal 5'-phosphate biosynthetic process Research
Researchers studying pyridoxal 5'-phosphate biosynthetic process-related genes often need to determine whether a candidate gene is causally involved in PLP production, how mutations affect enzyme function, or how overexpression impacts cellular metabolism. EDITGENE provides comprehensive CRISPR-based services to address these questions with precision and efficiency.
Contact EDITGENE today to design your custom CRISPR model for pyridoxal 5'-phosphate biosynthetic process research.
Frequently Asked Questions About pyridoxal 5'-phosphate biosynthetic process
What is pyridoxal 5'-phosphate biosynthetic process?
It is the biological process (GO:0042823) that produces pyridoxal 5'-phosphate (PLP), the active form of vitamin B6, through a series of enzymatic reactions.
What genes are involved in pyridoxal 5'-phosphate biosynthetic process?
Key genes include PdxS, PdxT, PdxH, PdxK, and PdxY in bacteria, and PLPBP in humans, among others [1,7].
Why is PLP important?
PLP is an essential cofactor for many enzymes involved in amino acid metabolism, neurotransmitter synthesis, and other vital processes.
How is PLP biosynthesis regulated?
It is regulated by feedback inhibition, transcriptional control, and phosphorylation of PLP-dependent enzymes [6,7].
What diseases are associated with PLP biosynthesis?
Hypertension, neurological disorders, and cancer have been linked to PLP metabolism [2,4,7].
Can CRISPR be used to study PLP biosynthesis?
Yes, CRISPR knockout, point mutation, and knock-in models are powerful tools to dissect gene function in PLP pathways [1,3].
What is the role of PLP in hypertension?
PLP antagonizes P2X3 receptors in the carotid body and may lower blood pressure, suggesting a therapeutic role.
How can I measure PLP levels?
PLP can be quantified using HPLC, mass spectrometry, or enzymatic assays.
What are PLP-dependent enzymes?
They are enzymes that require PLP as a cofactor, such as transaminases, decarboxylases, and racemases.
What model systems are used to study PLP biosynthesis?
Bacteria, yeast, mammalian cell lines, and mouse models are commonly used, often with CRISPR-based genetic modifications [1,3,5].
Conclusion
The pyridoxal 5'-phosphate biosynthetic process (GO:0042823) is a fundamental metabolic pathway that produces the active form of vitamin B6, a cofactor essential for numerous enzymatic reactions. Research into this process has revealed its importance in human health, from hypertension to neurological disorders, and its potential as a target for antimicrobial and anticancer therapies. Advances in CRISPR gene editing and omics technologies continue to illuminate the regulatory mechanisms and therapeutic opportunities associated with PLP biosynthesis.
References
- 1. Graziani C et al.. 2024. The ubiquitous pyridoxal 5'-phosphate-binding protein is also an RNA-binding protein.. Protein Sci 33(12):e5242 PMID: 39604152
- 2. Lellig M et al.. 2024. Pyridoxal-5'-phosphate: A cost-effective treatment candidate for hypertensive patients?. J Intern Med 296(5):435-448 PMID: 39385670
- 3. Chai W et al.. 2026. Pyridoxal 5'-Phosphate-Dependent Enzymatic Decarboxylative Annulation.. J Am Chem Soc 148(9):9709-9719 PMID: 41769737
- 4. Felippe ISA et al.. 2026. Vitamin B6 (Pyridoxal 5' Phosphate) antagonises carotid body P2X3 receptors in hypertension.. Cardiovasc Res 122(2):285-296 PMID: 41094718
- 5. Cui Z et al.. 2020. Pyridoxal-5'-phosphate-dependent alkyl transfer in nucleoside antibiotic biosynthesis.. Nat Chem Biol 16(8):904-911 PMID: 32483377
- 6. Rossignoli G et al.. 2018. Phosphorylation of pyridoxal 5'-phosphate enzymes: an intriguing and neglected topic.. Amino Acids 50(2):205-215 PMID: 29204749
- 7. Richard JP et al.. 2009. Pyridoxal 5'-phosphate: electrophilic catalyst extraordinaire.. Curr Opin Chem Biol 13(4):475-83 PMID: 19640775
- 8. Abad AND et al.. 2024. Discovery and Characterization of Pyridoxal 5'-Phosphate-Dependent Cycloleucine Synthases.. J Am Chem Soc 146(21):14672-14684 PMID: 38743881
